Partners & Medical Professionals
A wide body of evidence substantiates the efficacy of InsuJet™. Take a deeper dive into the research that speaks to its benefits.
The reports are in. Read the Clinical Evidence.
Needle-Free Insulin Administration
InsuJet™ works by pushing liquid under high pressure through a tiny orifice in the front of a nozzle, the liquid gets enough speed and pressure to pass through the skin. Once in the subcutaneous tissue, the liquid follows the path of least resistance, which ensures good distribution of the liquid.
One size fits all
Or better, one InsuJet™ is suitable for any size, gender, or age of subject. InsuJet™ may especially benefit people with a higher Body Mass Index (BMI).
Get started with the needle-free insulin injection system.
Disclaimers:
01. Compatible insulin types: Human and animal; Fast acting insulins (bolus); Rapid Acting Insulin Analogs; Regular Human Insulin; Basal insulins; Intermediate-acting, commonly: NPH/ Isophane; Long-acting, commonly: Glargine, detemir, degludec; Premixtures (e.g. 30/70).
02. In a user survey, 78% of respondents answered they would recommend InsuJet™ to others.
03. In a user survey, 40% of the respondents answered they noticed using less insulin.
04. Needle-Free Jet Injection of Rapid-Acting Insulin Improves Early Postprandial Glucose Control in Patients With Diabetes. Diabetes Care, October 2013.
05. Body mass index and the efficacy of needle-free jet injection for the administration of rapid-acting insulin analogs, a post hoc analysis. Diabetes, Obesity and Metabolism, July 2012.
06. Improved Pharmacokinetic and Pharmacodynamic Profile of Rapid-Acting Insulin Using Needle-Free Jet Injection Technology. Diabetes Care, August 2011
07. A Pilot Study to Examine the Tolerability and Device Preference in Type 1 Diabetes of Insulin Apart Administered by InsuJet™ Compared with Subcutaneous Injection. Diabetes Technology & Therapeutics, 2014.
08. See medical deck Cost Analysis - North America, 2022 available on the Partner page.
09. Calculated at 4 injections a day with a hypodermic needle. 4 injection a day, every day of the year, adds up to 1,460 needles a year saved from use.
*. The InsuJet™ is calibrated for U-100 insulins
**. Needle gauge 26-27 is commonly used for subcutaneous injections and is around 0.40 - 0.45mm in diameter. The orifice of the InsuJet™ Nozzle is about 0.15mm in diameter which is much smaller than conventional needle gauges used for subcutaneous insulin injections.
***. https://pubmed.ncbi.nlm.nih.gov PMID:18820853
The website uses cookies!